Kyoto Univ. institute to publish journal

Kyoto Univ. institute to publish journal

KYOTO, Japan - Norio Nakatsuji, professor and director at Kyoto University's Institute for Integrated Cell-Material Sciences, speaks during a press conference in Kyoto on Jan. 13, 2012. He said the institute will launch a journal this year titled ''Biomaterial Science'' to be published jointly with Britain's Royal Society of Chemistry.

  • Product Code
  • ILEA001165772
  • Registered date
  • 2012/1/13 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2012 Kyodo News
  • Media size
  • 1380 × 1867 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 333.49(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
    Japan Education Association estimates the cost of switching to September enrollment

    Japan Education Association estimates the cost of switching to September enrollment

    The Japan Society for Educational Research (JSSER) (Chiyoda Ward, Tokyo; Teruyuki Hirota, President; Professor, Nihon University, College of Letters, Science and Technology) has estimated the cost of the government's plan to switch to September enrollment, which totals more than 6 trillion yen. The government, local governments and households will have to pay more than 1.816 trillion yen to cover the cost of the change, which will lead to the improvement of not only emergency response to the new coronavirus infection but also long-term educational issues.Photo: Teruyuki Hirota (right), president, and Akio Inui, chairman of the special committee to study the issue of September enrollment and the first day of school, at a press conference on May 22, 2020, at the Ministry of Education, Culture, Sports, Science and Technology in Kasumigaseki, Chiyoda-ku, Tokyo.
      Press conference on the identification of existing drugs in Japan

      Press conference on the identification of existing drugs in Japan

      The photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo taking off his mask for explanation. (March 18, 2020, Yasuda Auditorium, University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
        Press conference on the identification of existing drugs in Japan

        Press conference on the identification of existing drugs in Japan

        Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
          Press conference on the identification of existing drugs in Japan

          Press conference on the identification of existing drugs in Japan

          Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
            Press conference on the identification of existing drugs in Japan

            Press conference on the identification of existing drugs in Japan

            Photo shows Professor Junichiro Inoue of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
              Press conference on the identification of existing drugs in Japan

              Press conference on the identification of existing drugs in Japan

              Photo shows Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                Press conference on the identification of existing drugs in Japan

                Press conference on the identification of existing drugs in Japan

                Photo shows Makoto Gogami, President of the University of Tokyo, at a press conference. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)
                  Press conference on the identification of existing drugs in Japan

                  Press conference on the identification of existing drugs in Japan

                  (From right) Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science of the University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science of the University of Tokyo, wearing masks at the press conference. The University of Tokyo's Yasuda Auditorium, Bunkyo Ward, Tokyo, March 18, 2020.
                    Press conference on the identification of existing drugs in Japan

                    Press conference on the identification of existing drugs in Japan

                    Scene of the press conference. (From right) Makoto Gogami, President of the University of Tokyo, Yuji Yamanashi, Director of the Institute of Medical Science, University of Tokyo, and Junichiro Inoue, Professor of the Institute of Medical Science, University of Tokyo. The University of Tokyo Yasuda Auditorium, Bunkyo-ku, Tokyo, March 18, 2020.
                      Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

                      Professor Inoue of University of Tokyo, announce the identification of a new coronavirus drug candidate

                      Professor Junichiro Inoue and his colleagues at the University of Tokyo's Institute of Medical Science held a press conference on April 18 and announced that they had identified nafamostat. Nafamostat has been used for more than 30 years in Japan, and early clinical trials are expected to be conducted. The clinical research is expected to start by the beginning of April in cooperation with the National Center for Global Health and Medicine and others. When the new corona infects humans, proteins on the surface of the virus and proteins on the surface of human cells bind to each other, causing the outer membrane of the virus to fuse with the membrane of human cells. As a result, ribonucleic acid (RNA), which is the genetic information of the new corona, enters the human cell, and the virus multiplies. (March 18, 2020, Yasuda Auditorium, The University of Tokyo, Bunkyo-ku, Tokyo; Credit: Nikkan Kogyo Shimbun / Kyodo News Images)